MedPath

M.D. ANDERSON CANCER CENTER

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2.9k

Active:463
Completed:1179

Trial Phases

6 Phases

Early Phase 1:76
Phase 1:723
Phase 2:1005
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2399 trials with phase data)• Click on a phase to view related trials

Phase 2
1005 (41.9%)
Phase 1
723 (30.1%)
Not Applicable
464 (19.3%)
Phase 3
102 (4.3%)
Early Phase 1
76 (3.2%)
Phase 4
29 (1.2%)

Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer

Not Applicable
Recruiting
Conditions
Advanced Cancer
First Posted Date
2025-08-05
Last Posted Date
2025-08-05
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
70
Registration Number
NCT07105033
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Not Applicable
Not yet recruiting
Conditions
Prostate Cancer
First Posted Date
2025-08-05
Last Posted Date
2025-08-05
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
40
Registration Number
NCT07105020
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Facilitators and Barriers to Cancer Treatment Among Texas Residents

Not Applicable
Not yet recruiting
Conditions
Cancer
First Posted Date
2025-08-05
Last Posted Date
2025-08-05
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
120
Registration Number
NCT07105046
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)

Not Applicable
Not yet recruiting
Conditions
Head and Neck Cancer
Interventions
First Posted Date
2025-08-03
Last Posted Date
2025-08-03
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
33
Registration Number
NCT07101432
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Opiophobia in Adults With Advanced Cancer

Recruiting
Conditions
Cancer
First Posted Date
2025-07-30
Last Posted Date
2025-08-07
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
50
Registration Number
NCT07093567
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 578
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.